Anishiya Abrol > Hogan Lovells US LLP > Washington DC, United States > Lawyer Profile
Hogan Lovells US LLP Offices
COLUMBIA SQUARE
555 THIRTEENTH STREET, NW
WASHINGTON DC 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Anishiya Abrol
Work Department
Intellectual Property
Position
Counsel
Career
Anishiya Abrol supports companies in their development and commercialization of cutting-edge medical therapies and tools. She advises on and negotiates a variety of strategic transactions from collaborations to in-licensing and out-licensing to maximize intellectual property assets, and then assists the company in implementing and integrating the new assets.
Anishiya has been seconded to multiple life sciences companies. She knows the issues facing in-house counsel and works closely with members of the firm’s Regulatory and Privacy Practice groups to provide integrated and practical advice.
Anishiya’s practice encompasses the full life sciences life cycle, from the discovery in the lab to dispensing to a patient. She has an undergraduate science degree, and her curious nature draws her towards early stage research and development transactions and activities, including clinical trial agreements, material transfer agreements, contract research organization (CRO) agreements, core lab agreements, sponsored research, grants, and technology transfers, both domestically and internationally. Recognizing though that a therapy’s primary value lies in the hands of patients, she assists commercialization efforts with support on distribution agreements, specialty pharmacy agreements, co-promotion agreements, authorized generic agreements, out-licensing arrangements, and other similar commercial activities.
Languages
English
Memberships
Chair, Wills for Heroes Program, Virginia Bar Association (2008-2013)
Member, American Health Law Association
Member, Virginia Bar Association
Education
J.D., George Mason University School of Law, magna cum laude, 2004
B.A. Biology, University of Virginia, 1997
B.A. History, University of Virginia, 1997
Lawyer Rankings
United States > Healthcare > Life sciences
(Next Generation Partners)Hogan Lovells US LLP houses a ‘highly knowledgeable and experienced‘ team of ‘real professionals with deep understanding’, capable of advising on IP litigation and the IP aspects of life sciences M&A, in addition to FDA compliance issues. Working out of the Philadelphia office, Steve Abrams advises on all manner of capital markets transactions involving orphan drugs, oncology therapies, and pain products, while Blake Wilson assists with the approval and pre-market clearance of novel medical devices. Anishiya Abrol focuses on the commercialization of medical therapies, as well as in-licensing and out-licensing, while Lynn Mehler often negotiates REMS systems and advises on the scheduling of newly approved controlled substances. Baltimore-based Lauren Colton heads up the product liability side of the practice, working closely with high-profile clients such as John Hopkins and Bristol-Myers Squibb. Randy Prebula has ample experience assisting combination and medical device product manufacturers bringing new medical devices and technology to market, and David Fox is particularly adept at acting in matters concerning FDA and Hatch-Waxman regulation. Northern Virginia’s Cullen Taylor frequently advises international pharmaceutical and biotech companies on co-promotion, collaboration, and licensing agreements. All named practitioners are based in Washington DC, unless specified otherwise.
Lawyer Rankings
- Next Generation Partners United States > Healthcare > Life sciences
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Transport > Aviation and air travel: litigation and regulation
- Antitrust > Cartel
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Industry focus > Education
- Government > Government relations
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Transport > Rail and road: litigation and regulation
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- International Trade > Trade remedies and trade policy
Firm Rankings
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- International Trade > CFIUS
- International Trade > Customs, export controls and economic sanctions
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Government > Government contracts
- Healthcare > Health insurers
- Healthcare > Life sciences
- Healthcare > Service providers
- Tax > US taxes: non-contentious
- Insurance > Advice to insurers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Energy > Energy regulation: electric power
- Finance > Fintech
- Labor and employment > Immigration
- Dispute resolution > International litigation
- Tax > International tax
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- M&A/corporate and commercial > Shareholder activism
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy litigation: oil and gas
- Finance > Project finance
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Finance > Project finance
- Dispute resolution > International arbitration
- Finance > Financial services regulation
- Investment fund formation and management > Private equity funds (including venture capital)